Biogen Inc.

NasdaqGS:BIIB

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

💊 Pharmaceuticals

Location

United States

Market Cap

USD 19.48 B

Share Price

USD 129.34

Avg Daily Volume

1,676,378

Change (1 day)

-2.67%

Change (1 year)

-35.37%

Change (YTD)

-15.42%

Biogen Inc. EBIT Margin for the Trailing 12 Months (TTM) ending June 30, 2025: 20.51%

Biogen Inc. EBIT Margin is 20.51% for the Trailing 12 Months (TTM) ending June 30, 2025, a 18.22% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.

Biogen Inc. EBIT Margin for the Trailing 12 Months (TTM) ending June 30, 2024 was 17.35%, a -33.57% change year over year.
Biogen Inc. EBIT Margin for the Trailing 12 Months (TTM) ending June 30, 2023 was 26.11%, a 24.74% change year over year.
Biogen Inc. EBIT Margin for the Trailing 12 Months (TTM) ending June 30, 2022 was 20.93%, a -17.04% change year over year.
Biogen Inc. EBIT Margin for the Trailing 12 Months (TTM) ending June 30, 2021 was 25.24%, a -51.79% change year over year.